Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine, Oxaliplatin, and Radiotherapy in Pancreatic/Biliary Cancer
NCT00286013Phase 2Completed
- Sponsor
- Ghent University Hospital
- Start
- May 2004
- Primary completion
- May 2006
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, oxaliplatin in pancreatic adenocarcinoma (PDAC), distal cholangiocarcinoma (dCCA), sponsored by Ghent University Hospital. Started May 2004; status: completed.
02
Drugs
gemcitabineoxaliplatin
03
Conditions
pancreatic adenocarcinoma (PDAC)distal cholangiocarcinoma (dCCA)
Beyond the preview
Go deeper on NCT00286013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00286013.